A study published last year in the Lancet showing the merits of treating breast cancer with intraoperative radiation therapy (IORT) offered hope that the technique could be a safer alternative to traditional treatment. But not everybody is convinced.
The randomized controlled trial found IORT could prevent cancer from returning while also limiting the side effects seen with lengthier traditional treatments. However, some have criticized the design of the study and others say traditional radiation does a better job of controlling recurrence.
The Wall Street Journal checks in on the debate at the link below: